JP2017081972A5 - - Google Patents

Download PDF

Info

Publication number
JP2017081972A5
JP2017081972A5 JP2017000107A JP2017000107A JP2017081972A5 JP 2017081972 A5 JP2017081972 A5 JP 2017081972A5 JP 2017000107 A JP2017000107 A JP 2017000107A JP 2017000107 A JP2017000107 A JP 2017000107A JP 2017081972 A5 JP2017081972 A5 JP 2017081972A5
Authority
JP
Japan
Prior art keywords
composition
mesenchymal stem
stem cells
pharmaceutically acceptable
serum albumin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017000107A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017081972A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2017081972A publication Critical patent/JP2017081972A/ja
Publication of JP2017081972A5 publication Critical patent/JP2017081972A5/ja
Pending legal-status Critical Current

Links

JP2017000107A 2008-08-14 2017-01-04 精製済み間葉系幹細胞組成物および間葉系幹細胞組成物を精製する方法 Pending JP2017081972A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8889808P 2008-08-14 2008-08-14
US61/088,898 2008-08-14

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2014224180A Division JP2015071610A (ja) 2008-08-14 2014-11-04 精製済み間葉系幹細胞組成物および間葉系幹細胞組成物を精製する方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018036415A Division JP2018109052A (ja) 2008-08-14 2018-03-01 精製済み間葉系幹細胞組成物および間葉系幹細胞組成物を精製する方法

Publications (2)

Publication Number Publication Date
JP2017081972A JP2017081972A (ja) 2017-05-18
JP2017081972A5 true JP2017081972A5 (enExample) 2017-09-21

Family

ID=41669330

Family Applications (7)

Application Number Title Priority Date Filing Date
JP2011523195A Active JP6025329B2 (ja) 2008-08-14 2009-08-14 精製済み間葉系幹細胞組成物および間葉系幹細胞組成物を精製する方法
JP2014224180A Pending JP2015071610A (ja) 2008-08-14 2014-11-04 精製済み間葉系幹細胞組成物および間葉系幹細胞組成物を精製する方法
JP2017000107A Pending JP2017081972A (ja) 2008-08-14 2017-01-04 精製済み間葉系幹細胞組成物および間葉系幹細胞組成物を精製する方法
JP2018036415A Pending JP2018109052A (ja) 2008-08-14 2018-03-01 精製済み間葉系幹細胞組成物および間葉系幹細胞組成物を精製する方法
JP2020072934A Active JP7580202B2 (ja) 2008-08-14 2020-04-15 精製済み間葉系幹細胞組成物および間葉系幹細胞組成物を精製する方法
JP2023000381A Pending JP2023052211A (ja) 2008-08-14 2023-01-05 精製済み間葉系幹細胞組成物および間葉系幹細胞組成物を精製する方法
JP2025086455A Pending JP2025122125A (ja) 2008-08-14 2025-05-23 精製済み間葉系幹細胞組成物および間葉系幹細胞組成物を精製する方法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2011523195A Active JP6025329B2 (ja) 2008-08-14 2009-08-14 精製済み間葉系幹細胞組成物および間葉系幹細胞組成物を精製する方法
JP2014224180A Pending JP2015071610A (ja) 2008-08-14 2014-11-04 精製済み間葉系幹細胞組成物および間葉系幹細胞組成物を精製する方法

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2018036415A Pending JP2018109052A (ja) 2008-08-14 2018-03-01 精製済み間葉系幹細胞組成物および間葉系幹細胞組成物を精製する方法
JP2020072934A Active JP7580202B2 (ja) 2008-08-14 2020-04-15 精製済み間葉系幹細胞組成物および間葉系幹細胞組成物を精製する方法
JP2023000381A Pending JP2023052211A (ja) 2008-08-14 2023-01-05 精製済み間葉系幹細胞組成物および間葉系幹細胞組成物を精製する方法
JP2025086455A Pending JP2025122125A (ja) 2008-08-14 2025-05-23 精製済み間葉系幹細胞組成物および間葉系幹細胞組成物を精製する方法

Country Status (14)

Country Link
US (6) US8637004B2 (enExample)
EP (3) EP3124601A1 (enExample)
JP (7) JP6025329B2 (enExample)
AR (2) AR073069A1 (enExample)
AU (1) AU2009281809B2 (enExample)
BR (1) BRPI0917993B8 (enExample)
CA (1) CA2733985C (enExample)
DK (1) DK2318519T3 (enExample)
ES (1) ES2608974T3 (enExample)
IL (1) IL211214A0 (enExample)
MX (2) MX362512B (enExample)
NZ (2) NZ602248A (enExample)
WO (1) WO2010019886A1 (enExample)
ZA (1) ZA201101858B (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005093044A1 (en) 2004-03-22 2005-10-06 Osiris Therapeutics, Inc. Mesenchymal stem cells and uses therefor
US20070258963A1 (en) 2006-01-13 2007-11-08 Osiris Therapeutics, Inc. Mesenchymal stem cells expressing TNF-alpha receptors
NZ602248A (en) 2008-08-14 2014-03-28 Osiris Therapeutics Inc Purified mesenchymal stem cell compositions and methods of purifying mesenchymal stem cell compositions
DK2330889T3 (en) 2008-08-20 2017-01-30 Anthrogenesis Corp Improved cell composition and process for making the same
US9192695B2 (en) 2008-11-20 2015-11-24 Allosource Allografts combined with tissue derived stem cells for bone healing
WO2012048275A2 (en) 2010-10-08 2012-04-12 Caridianbct, Inc. Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
US20120087933A1 (en) 2010-10-08 2012-04-12 Samson Tom Enhanced msc preparations
ITGE20120034A1 (it) * 2012-03-28 2013-09-29 Carlo Tremolada Preparato e metodo per la produzione di un preparato comprendente cellule staminali mesenchimali
JP2013252126A (ja) * 2012-05-08 2013-12-19 Otsuka Pharmaceut Factory Inc デキストラン含有肺塞栓形成予防用哺乳動物細胞懸濁液
WO2014150784A1 (en) 2013-03-15 2014-09-25 Allosource Cell repopulated collagen matrix for soft tissue repair and regeneration
CN105793411B (zh) 2013-11-16 2018-04-17 泰尔茂比司特公司 生物反应器中的细胞扩增
JP6783143B2 (ja) 2014-03-25 2020-11-11 テルモ ビーシーティー、インコーポレーテッド 培地の受動的補充
US20160090569A1 (en) 2014-09-26 2016-03-31 Terumo Bct, Inc. Scheduled Feed
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
EP3238760B1 (en) 2016-04-29 2019-10-02 Fenwal, Inc. System and method for selecting and culturing cells
US10251990B2 (en) 2016-04-29 2019-04-09 Fenwal, Inc. System and method for processing, incubating, and/or selecting biological cells
US11965175B2 (en) 2016-05-25 2024-04-23 Terumo Bct, Inc. Cell expansion
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
EP3338823B1 (en) 2016-12-21 2021-06-16 Fenwal, Inc. System and method for separating cells incorporating magnetic separation
US12234441B2 (en) 2017-03-31 2025-02-25 Terumo Bct, Inc. Cell expansion
US11629332B2 (en) 2017-03-31 2023-04-18 Terumo Bct, Inc. Cell expansion
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
AU2018372631B2 (en) 2017-11-22 2025-06-05 Mesoblast International Sarl Cellular compositions and methods of treatment I
EP3781597A1 (en) 2018-04-18 2021-02-24 Xencor, Inc. Lag-3 targeted heterodimeric fusion proteins containing il-15/il-15ra fc-fusion proteins and lag-3 antigen binding domains
EP3847241A1 (en) * 2018-10-26 2021-07-14 Stemselect Method and apparatus for mesenchymal stem cells isolation and purification
CN113438961A (zh) 2018-12-20 2021-09-24 Xencor股份有限公司 含有IL-15/IL-15Rα和NKG2D抗原结合结构域的靶向异二聚体Fc融合蛋白
CA3137570A1 (en) * 2019-05-15 2020-11-19 Stemcyte Inc. High concentration cell packaging and shipping
WO2021144995A1 (ja) * 2020-01-16 2021-07-22 ＰｕＲＥＣ株式会社 高純度間葉系幹細胞
WO2021226373A2 (en) 2020-05-08 2021-11-11 Gallant Pet, Inc. Uterine-derived regenerative cell compositions and uses thereof
EP4314244B1 (en) 2021-03-23 2025-07-23 Terumo BCT, Inc. Cell capture and expansion
US12152699B2 (en) 2022-02-28 2024-11-26 Terumo Bct, Inc. Multiple-tube pinch valve assembly
USD1099116S1 (en) 2022-09-01 2025-10-21 Terumo Bct, Inc. Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device
CN115478046A (zh) * 2022-09-30 2022-12-16 浙江泉生生物科技有限公司 一种降低血清培养体系中细胞制剂bsa残留量的方法

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5034135A (en) 1982-12-13 1991-07-23 William F. McLaughlin Blood fractionation system and method
US4803075A (en) * 1986-06-25 1989-02-07 Collagen Corporation Injectable implant composition having improved intrudability
JP2881305B2 (ja) 1986-08-11 1999-04-12 バクスター、インターナショナル、インコーポレイテッド 血球洗浄システムおよび方法
US5536475A (en) 1988-10-11 1996-07-16 Baxter International Inc. Apparatus for magnetic cell separation
US5226914A (en) 1990-11-16 1993-07-13 Caplan Arnold I Method for treating connective tissue disorders
US5197985A (en) 1990-11-16 1993-03-30 Caplan Arnold I Method for enhancing the implantation and differentiation of marrow-derived mesenchymal cells
US5837539A (en) 1990-11-16 1998-11-17 Osiris Therapeutics, Inc. Monoclonal antibodies for human mesenchymal stem cells
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US5234608A (en) 1990-12-11 1993-08-10 Baxter International Inc. Systems and methods for processing cellular rich suspensions
CA2192103C (en) * 1994-06-06 2002-02-05 Arnold I. Caplan Biomatrix for tissue regeneration
US5707996A (en) * 1995-11-06 1998-01-13 Macleod Pharmaceuticals, Inc. Pharmaceutical solution and methods for preparation thereof
CA2251983C (en) * 1996-04-19 2003-12-16 Sudhakar Kadiyala Regeneration and augmentation of bone using mesenchymal stem cells
US5827740A (en) * 1996-07-30 1998-10-27 Osiris Therapeutics, Inc. Adipogenic differentiation of human mesenchymal stem cells
ATE307195T1 (de) * 1997-07-14 2005-11-15 Osiris Therapeutics Inc Herzmuskelregenerierung unter verwendung mesenchymaler stammzellen
US6251295B1 (en) 1998-01-08 2001-06-26 Nexell Therapeutics Inc. Method for recirculation washing of blood cells
EP1066052B1 (en) 1998-03-18 2006-02-01 Osiris Therapeutics, Inc. Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
CA2328425A1 (en) * 1998-05-22 1999-12-02 Osiris Therapeutics, Inc. Production of megakaryocytes by co-culturing human mesenchymal stem cells with cd34+ cells
FR2787463B1 (fr) 1998-12-21 2001-03-30 Neurotech Preparation de cellules de mammifere eventuellement transfectees avec un gene codant pour une substance active et les compositions les contenant
JP2002325572A (ja) * 2000-12-25 2002-11-12 Univ Osaka 外来物質の導入方法
US20030054331A1 (en) 2001-09-14 2003-03-20 Stemsource, Inc. Preservation of non embryonic cells from non hematopoietic tissues
US20050095228A1 (en) 2001-12-07 2005-05-05 Fraser John K. Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
US20050008626A1 (en) 2001-12-07 2005-01-13 Fraser John K. Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
US20050048035A1 (en) 2001-12-07 2005-03-03 Fraser John K. Methods of using regenerative cells in the treatment of stroke and related diseases and disorders
US9597395B2 (en) 2001-12-07 2017-03-21 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
US20050048036A1 (en) 2001-12-07 2005-03-03 Hedrick Marc H. Methods of using regenerative cells in the treatment of inherited and acquired disorders of the bone, bone marrow, liver, and other tissues
US7585670B2 (en) 2001-12-07 2009-09-08 Cytori Therapeutics, Inc. Automated methods for isolating and using clinically safe adipose derived regenerative cells
US7514075B2 (en) 2001-12-07 2009-04-07 Cytori Therapeutics, Inc. Systems and methods for separating and concentrating adipose derived stem cells from tissue
KR100930139B1 (ko) 2001-12-07 2009-12-07 사이토리 테라퓨틱스, 인크. 처리된 리포애스퍼레이트 세포로 환자를 치료하기 위한시스템 및 방법
US8404229B2 (en) 2001-12-07 2013-03-26 Cytori Therapeutics, Inc. Methods of using adipose derived stem cells to treat acute tubular necrosis
ITTO20020311A1 (it) * 2002-04-10 2003-10-10 Medestea Int Spa Procedimento per la preparazione di cellule staminali da tessuto muscolare e tessuto adiposo umano e cellule staminali ottenibili mediante t
ZA200404101B (en) 2003-05-26 2005-03-07 Reliance Life Sciences Pvt Ltd In vitro culture of Mesenchymal Stem Cells (MSC) and a process for the preparation thereof for therapeutic use.
CA2530630A1 (en) 2003-06-25 2005-02-10 Macropore Biosurgery Inc. Systems and methods for separating and concentrating regenerative cells from tissue
WO2005093044A1 (en) * 2004-03-22 2005-10-06 Osiris Therapeutics, Inc. Mesenchymal stem cells and uses therefor
JP3828905B2 (ja) * 2004-08-05 2006-10-04 株式会社Ｒ＆Ｄセルサイエンス・オプショナルメディコ 局所麻酔薬を含有する細胞凝集抑制剤
US8512724B2 (en) * 2005-06-10 2013-08-20 The Board Of Regents Of The University Of Texas System Antiseptic compositions
AU2006292203A1 (en) 2005-09-21 2007-03-29 Dask Technologies, Llc Methods and compositions for organ and tissue functionality
US7888119B2 (en) * 2005-10-14 2011-02-15 University Of Central Florida Research Foundation, Inc. Tissue substitutes comprising stem cells and reduced ceria
US20070253931A1 (en) * 2006-01-12 2007-11-01 Osiris Therapeutics, Inc. Use of mesenchymal stem cells for treating genetic diseases and disorders
WO2007089798A2 (en) 2006-01-30 2007-08-09 University Of Virginia Patent Foundation Methods of preparing and characterizing mesenchymal stem cell aggregates and uses thereof
US8679809B2 (en) 2006-05-19 2014-03-25 The University Of Hong Kong Cell-matrix microspheres, methods for preparation and applications
EP2617428A1 (en) 2006-08-15 2013-07-24 Agency for Science, Technology and Research Mesenchymal stem cell conditioned medium
ES2362150T3 (es) * 2006-11-03 2011-06-29 Aastrom Biosciences, Inc. Poblaciones celulares mixtas para la reparación de tejidos y técnica de separación para el procesamiento celular.
JP2008139106A (ja) * 2006-11-30 2008-06-19 Sysmex Corp 骨髄穿刺液収容具及び骨髄穿刺液濾過方法
WO2008073331A2 (en) 2006-12-07 2008-06-19 Teva Pharmaceutical Industries Ltd. Method of generation and expansion of tissue-progenitor cells and mature tissue cells from intact bone marrow or intact umbilical cord tissue
CN101210232B (zh) * 2006-12-28 2012-07-18 天津昂赛细胞基因工程有限公司 一种间充质干细胞保存液
EP2191835A4 (en) 2007-09-07 2011-12-14 Japan Chem Res THERAPEUTIC AND PROPHYLACTIC AGENTS FOR ARTHRITIS
EP2210608B1 (en) 2007-11-02 2016-08-31 JCR Pharmaceuticals CO., LTD. Pharmaceutical composition containing human mesenchymal stem cell
NZ602248A (en) 2008-08-14 2014-03-28 Osiris Therapeutics Inc Purified mesenchymal stem cell compositions and methods of purifying mesenchymal stem cell compositions
US8048976B2 (en) 2008-09-04 2011-11-01 Amyris, Inc. Polyfarnesenes
US10476476B2 (en) 2016-12-15 2019-11-12 Murata Manufacturing Co., Ltd. MEMS resonator with suppressed spurious modes

Similar Documents

Publication Publication Date Title
JP2018109052A5 (enExample)
JP2017081972A5 (enExample)
JP2018193377A5 (enExample)
JP2017525671A5 (enExample)
JP2012515221A5 (enExample)
JP2015517489A5 (enExample)
JP2014129360A5 (enExample)
PE20130574A1 (es) Nuevas formas de dosificacion de liberacion modificada de un inhibidor de la xantina oxidorreductasa o de inhibidores de xantina oxidasa
NZ591146A (en) Composition comprising mesenchymal stem cell aggregates wherein the D90 of said aggregates is less than 150 micomills
JP2005524658A5 (enExample)
MA33374B1 (fr) Composition de surfactant reconstitué améliorée contenant des analogues de la protéine b du surfactant (sp-b) et de la protéine c du surfactant (sp-c)
JP2014508138A5 (enExample)
WO2011139357A8 (en) Adult stem cells/progenitor cells and stem cell proteins for treatment of eye injuries and diseases
JP2013520405A5 (enExample)
JP2014509319A5 (enExample)
JP2016511753A5 (enExample)
JP2014527040A5 (enExample)
JP2017532343A5 (enExample)
JP2012136518A5 (enExample)
JP2017141225A5 (enExample)
JP2015526455A5 (enExample)
WO2008013630A3 (en) Calcium aluminosilicate pharmaceutical
AR062979A1 (es) Formulaciones orales liofilizadas de desintegracion rapida de un antagonista del receptor de trombina
EA201791138A1 (ru) Фармацевтическая композиция, ее приготовление и применения
JP2012515165A5 (enExample)